NASDAQ: AKTX       Akari Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
1.58   -0.01 (0.63%)  1.58 - 1.67  6,278


Avg Volume (4 weeks):166,805
4 Weeks Range:1.53 - 1.99
4 Weeks Price Volatility (%):
52 Weeks Range:0.87 - 2.79
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. The firm earns majority of its revenues from United Kingdom. It operates mainly in United States and United Kingdom.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2434  3263  557  3142 

Top 10 Active Counters
 LK 1.38+1.38 
 OAS 0.155-0.014 
 BLRX 2.12+0.64 
 NIO 30.841-1.149 
 AAPL 109.54-5.78 
 HTZ 1.780.00 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 TWTR 42.85-9.58 
 XOG 0.271-0.062